Show simple item record

dc.contributor.authorKaro, Basel
dc.contributor.authorKrause, Gerard
dc.contributor.authorCastell, Stefanie
dc.contributor.authorKollan, Christian
dc.contributor.authorHamouda, Osamah
dc.contributor.authorHaas, Walter
dc.date.accessioned2017-08-03T14:32:51Z
dc.date.available2017-08-03T14:32:51Z
dc.date.issued2017-07-25
dc.identifier.citationImmunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. 2017, 17 (1):517 BMC Infect. Dis.en
dc.identifier.issn1471-2334
dc.identifier.pmid28743248
dc.identifier.doi10.1186/s12879-017-2627-y
dc.identifier.urihttp://hdl.handle.net/10033/621040
dc.description.abstractUnderstanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of TB.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleImmunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.en
dc.typeArticleen
dc.identifier.journalBMC infectious diseasesen
refterms.dateFOA2018-06-12T18:10:32Z
html.description.abstractUnderstanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of TB.


Files in this item

Thumbnail
Name:
Karo et al.pdf
Size:
748.9Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/